rs41281938

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_014290.3(TDRD7):​c.1923G>A​(p.Lys641Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0317 in 1,613,386 control chromosomes in the GnomAD database, including 1,070 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.044 ( 198 hom., cov: 32)
Exomes 𝑓: 0.030 ( 872 hom. )

Consequence

TDRD7
NM_014290.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.35

Publications

3 publications found
Variant links:
Genes affected
TDRD7 (HGNC:30831): (tudor domain containing 7) The protein encoded by this gene belongs to the Tudor family of proteins. This protein contains conserved Tudor domains and LOTUS domains. It is a component of RNA granules, which function in RNA processing. Mutations in this gene have been associated with cataract formation in mouse and human. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
TDRD7 Gene-Disease associations (from GenCC):
  • cataract 36
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 9-97472474-G-A is Benign according to our data. Variant chr9-97472474-G-A is described in ClinVar as Benign. ClinVar VariationId is 364071.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.35 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0879 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TDRD7NM_014290.3 linkc.1923G>A p.Lys641Lys synonymous_variant Exon 10 of 17 ENST00000355295.5 NP_055105.2 Q8NHU6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TDRD7ENST00000355295.5 linkc.1923G>A p.Lys641Lys synonymous_variant Exon 10 of 17 1 NM_014290.3 ENSP00000347444.4 Q8NHU6-1

Frequencies

GnomAD3 genomes
AF:
0.0441
AC:
6702
AN:
152062
Hom.:
199
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0906
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0261
Gnomad ASJ
AF:
0.0222
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0330
Gnomad FIN
AF:
0.0134
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0307
Gnomad OTH
AF:
0.0368
GnomAD2 exomes
AF:
0.0288
AC:
7168
AN:
249128
AF XY:
0.0287
show subpopulations
Gnomad AFR exome
AF:
0.0938
Gnomad AMR exome
AF:
0.0157
Gnomad ASJ exome
AF:
0.0219
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.0144
Gnomad NFE exome
AF:
0.0304
Gnomad OTH exome
AF:
0.0269
GnomAD4 exome
AF:
0.0304
AC:
44417
AN:
1461206
Hom.:
872
Cov.:
31
AF XY:
0.0306
AC XY:
22212
AN XY:
726920
show subpopulations
African (AFR)
AF:
0.0918
AC:
3071
AN:
33448
American (AMR)
AF:
0.0166
AC:
740
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0222
AC:
580
AN:
26124
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39662
South Asian (SAS)
AF:
0.0349
AC:
3008
AN:
86248
European-Finnish (FIN)
AF:
0.0140
AC:
746
AN:
53330
Middle Eastern (MID)
AF:
0.0356
AC:
205
AN:
5764
European-Non Finnish (NFE)
AF:
0.0308
AC:
34234
AN:
1111554
Other (OTH)
AF:
0.0302
AC:
1825
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
2077
4153
6230
8306
10383
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1318
2636
3954
5272
6590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0440
AC:
6701
AN:
152180
Hom.:
198
Cov.:
32
AF XY:
0.0424
AC XY:
3156
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0903
AC:
3747
AN:
41502
American (AMR)
AF:
0.0262
AC:
400
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0222
AC:
77
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5174
South Asian (SAS)
AF:
0.0334
AC:
161
AN:
4818
European-Finnish (FIN)
AF:
0.0134
AC:
142
AN:
10598
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0307
AC:
2090
AN:
68016
Other (OTH)
AF:
0.0364
AC:
77
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
307
614
920
1227
1534
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0359
Hom.:
87
Bravo
AF:
0.0464
Asia WGS
AF:
0.0130
AC:
47
AN:
3478
EpiCase
AF:
0.0309
EpiControl
AF:
0.0294

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cataract 36 Benign:2
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
May 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.39
CADD
Benign
6.6
DANN
Benign
0.64
PhyloP100
1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41281938; hg19: chr9-100234756; COSMIC: COSV107439754; API